EdwardWilliamGreenoMD
Oncology • Minneapolis, MNGastrointestinal Cancer, Hematologic Oncology
Professor, Medicine, University of Minnesota Medical; Chief, University of Minnesota Health Cancer Care
Dr. Greeno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-625-3600Fax+1 612-625-6919
Summary
- Dr. Edward Greeno is an oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including University of Minnesota Medical Center, Fairview, Fairview Ridges Hospital, Fairview Southdale Hospital, Fairview Lakes Health Services, and Fairview Northland Medical Center. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 31 years. He specializes in gastrointestinal cancer and hematologic oncology and is experienced in pancreatic adenocarcinoma, neuroendocrine carcinomas, and gastrointestinal oncology.
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1990 - 1995- University of MinnesotaResidency, Internal Medicine, 1986 - 1990
Case Western Reserve University School of MedicineClass of 1986
Certifications & Licensure
MN State Medical License 1988 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chemoradiation in Locally Advanced Pancreatic Cancer Start of enrollment: 2005 Jan 01
- Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy Start of enrollment: 2009 Sep 01
- IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 73 citationsRuxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III stu...Herbert Hurwitz, Eric Van Cutsem, Johanna C. Bendell, Manuel Hidalgo, Chung Pin Li
Investigational New Drugs. 2018-03-06 - 36 citationsDevelopment of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinom...David Goldstein, Daniel D. Von Hoff, Malcolm A.S. Moore, Edward W Greeno, Giampaolo Tortora
European Journal of Cancer. 2016-01-01 - 251 citationsChemotherapy-induced thrombosis.Tufia C. Haddad, Edward W Greeno
Thrombosis Research. 2006-01-01
Press Mentions
mHealth Proves Better at Medication Adherence Than Eyes-on TherapyOctober 10th, 2019
Younger Brother’s Pancreatic Cancer Leads to Regular Screening for His Oldest BrotherJune 6th, 2019
A ‘Digital Pill’ for Cancer Patients Is Rolled Out for the First Time, in Hopes of Improving OutcomesJanuary 28th, 2019- Join now to see all
Grant Support
- UAB/UMN SPORE in Pancreatic CancerNIH/NCI2003–Present
- Surface Regulation Of Tissue Factor ActivityNational Heart, Lung, And Blood Institute1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
